January 24, 2015 11:15 PM ET

Healthcare Equipment and Supplies

Company Overview of Oxford Immunotec Global PLC

Company Overview

Oxford Immunotec Global PLC, a diagnostics company, focuses on the provision of various tests in the field of immunology in the United States, Europe, Japan, and China. The company develops its products using its T-SPOT technology platform, which enables the measurement of responses of specific immune cells to inform the diagnosis, prognosis, and monitoring of patients with immunologically controlled diseases. Its solution includes SPOT.TB test, a single-cell based method for identifying latent tuberculosis infection. The company was founded in 2002 and is headquartered in Abingdon, the United Kingdom.

94C Innovation Drive

Milton Park

Abingdon,  OX14 4RZ

United Kingdom

Founded in 2002

223 Employees


44 1235 442780

Key Executives for Oxford Immunotec Global PLC

Chief Executive Officer and Director
Age: 40
Total Annual Compensation: $330.4K
Chief Financial Officer and Principal Accounting Officer
Age: 54
Total Annual Compensation: $255.0K
Chief Commercial Officer
Age: 53
Total Annual Compensation: $276.8K
Compensation as of Fiscal Year 2013.

Oxford Immunotec Global PLC Key Developments

Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test

Oxford Immunotec Global PLC announced that the company's T-SPOT®.TB test has completed the re-registration process with the China Food and Drug Administration (CFDA). The registration became effective December 11, 2014 and lasts for five years.

Oxford Immunotec Global PLC Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM

Oxford Immunotec Global PLC Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-14-2015 03:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Peter Wrighton-Smith, Chief Executive Officer and Director, Richard M. Altieri, Chief Financial Officer and Principal Accounting Officer.

Oxford Immunotec Global PLC Appoints James R. Tobin to its Board of Directors

Oxford Immunotec Global PLC announced the appointment of James R. Tobin to its Board of Directors. Mr. Tobin served as President and Chief Executive Officer of Boston Scientific from March 1999 to July 2009 during which time the company's revenues grew from more than $2 billion to over $8 billion.

Similar Private Companies By Industry

Company Name Region
S.S. White Manufacturing Limited Europe
Plasma Surgical Limited Europe
Leicester Optical Limited Europe
ChangeAlert Europe
Osmetech plc Europe

Recent Private Companies Transactions

August 5, 2014
Boulder Diagnostics Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oxford Immunotec Global PLC, please visit www.oxfordimmunotec.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.